Use of Erbium Laser in the Treatment of a Patient with Acute Purulent Periostitis and a Resistant Form of Primary Immune Thrombocytopenia

Larionova, Elena; Тарасенко, С. В.; Морозова, Е. А.; Diachkova, Ekaterina

doi:10.1155/2019/8260605

Cited by 5 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Очевидно, что комплексное лечение экспериментального периостита, включающее лазерное воздействие, примененное с первых суток послеоперационного периода, является эффективным для купирования инфекционно-воспалительного процесса, а также создает оптимальные условия для регенерации поврежденных им тканей, что согласуется со сведениями E. Larionova et al (2019) [8].…”

Section: результаты и обсуждениеunclassified

Untitled

2022

Vestnik VSMU

View full text Add to dashboard Cite

Рецензируемый научно-практический журнал. Основан в 2002 году. Периодичность -6 раз в год. Учредитель и издатель -Учреждение образования «Витебский государственный ордена Дружбы народов медицинский университет» Журнал является членом Cross Ref и Ассоциации научных редакторов и издателей (АНРИ).

show abstract

Section: результаты и обсуждениеunclassified

Untitled

2022

Vestnik VSMU

View full text Add to dashboard Cite

show abstract

“…Among them, periostitis is one of the common bone diseases, and there are many types of it, such as proliferative periostitis [2], periostitis associated with osteo brosis [3], and tibial periostitis [4]. Currently, the clinical methods used to treat periostitis include laser therapy [5], drug therapy [6], oating needle therapy [7], microwave therapy combined with acupuncture [8], traditional Chinese massage therapy [9], etc. However, laser therapy is expensive, drugs have obvious side effects on the stomach and intestines, and the treatment period of traditional Chinese therapy is long, so there is a lack of a safe and effective treatment method for periostitis.…”

Section: Introductionmentioning

confidence: 99%

Isolation, culture and biological characteristics of duck periosteum stem cells in vitro

wang

liu

Zong

et al. 2023

Preprint

View full text Add to dashboard Cite

Mesenchymal stem cells (MSCs), known as seed cells, have been shown to be useful in repairing damaged or diseased tissues and organs in the past. However, its clinical application in vivo is limited by individual differences and diversity of sources. In contrast, periosteum or periosteum-derived stem cells (PSCS) are more appropriate for fracture or cartilage damage. PC is also known as MSCs, but it is not clear whether PC is a class of cells of MSCs. Our objective was to isolate the PC of the periosteum of the duck embryo tibia and study its properties. The femoral periosteum of duck embryos at 12 days of age was easily collected, and the isolated cells showed typical stem cell morphology by enzyme digestion and adhesion method. Both immunofluorescence detection and RT-PCR showed that PSC could express CD90, CD29, CD166 and CD44 on the surface of MSCs, but not CD34 on the surface of hematopoietic stem cells. Under different culture conditions, PSC was proved to have the ability to differentiate into adipocytes, osteoblasts and chondroblasts in vitro. In addition, PC also has a strong ability to proliferate and self-renewal ability. In conclusion, our study suggests that PSCS may contain MSCs, which can be used as one of the candidate resources for clinical treatment of bone diseases.

show abstract

Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline

Dijk

Corrêa

Schutgens

et al. 2021

TH Open

View full text Add to dashboard Cite

Background Dentoalveolar procedures in immune thrombocytopenia (ITP) pose a risk of bleeding, due to thrombocytopenia, and infection, due to immunosuppressive treatments. We aimed to systematically review the safety and management of dentoalveolar procedures in ITP patients in order to create practical recommendations. Methods Pubmed, Embase, Cochrane and Cinahl were searched for original studies on dentoalveolar procedures in known primary ITP patients. We recorded bleeding- and infection-related outcomes and therapeutic strategies. Clinically relevant bleeding was defined as needing medical attention. Results Seventeen articles were included, of which twelve case reports/series. Overall, the quality of the available evidence was poor. Outcomes and administered therapies (including hemostatic therapies and prophylactic antibiotics) were not systematically reported. At least 73 dentoalveolar procedures in 49 ITP patients were described. The range of preoperative platelet count was 2-412*109/L. Two clinically relevant bleedings (2%) were reported in the same patient, of which one was life-threatening. Strategies used to minimalize the risk of bleeding were heterogeneous and included therapies to increase platelet count, antifibrinolytics, local measures and minimally invasive techniques. Reports on the occurrence of bleedings due to anesthetics or infection were lacking. Conclusion Based on alarmingly limited data, clinically relevant bleedings and infections after dentoalveolar procedures in ITP patients seem rare. Awaiting prospective and controlled studies to further evaluate these risks and the efficacy of therapeutic interventions, we provided our institutional guideline to guide the management of dentoalveolar procedures in ITP patients.

show abstract

Use of Erbium Laser in the Treatment of a Patient with Acute Purulent Periostitis and a Resistant Form of Primary Immune Thrombocytopenia

Cited by 5 publications

References 10 publications

Untitled

Untitled

Isolation, culture and biological characteristics of duck periosteum stem cells in vitro

Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline

Contact Info

Product

Resources

About